32 results about "Upper Respiratory Tract Inflammation" patented technology

The invention describes a method of treating upper airway disease by administering a composition of one or more proinflammatory cytokine inhibitors sufficient to inhibit inflammation in the upper airways. The proinflammatory cytokines that are inhibited include TNF, IL-1 and IL-8. A medication dispensing unit which includes a container and a delivery system is used to administer the composition. The delivery system further encompasses a one-way valve, a microcatheter, or a liquid-pressure type sprayer.

A Chinese medicine for treating laryngolaryngitis and upper respiratory tract inflammation is prepared from 10 Chinese-medicinal materials including scrophularia root, ophiopogon root, ciccada slough, myrobalan seed, etc through proportionally mixing, extracting and mixing with sugar or syrup and additive.

The invention relates to a complex traditional Chinese medicine preparation for treating upper respiratory tract infection and a preparation method thereof. The complex traditional Chinese medicine preparation comprises the following raw materials: 10-25 parts of picria felterrae lour, 5-15 parts of herba sarcandrae, 5-15 parts of senecio, 5-13 parts of pubescent holly root and 1-5 parts of liquorice. The preparation method comprises the following steps: pulverizing a proper amount of picria felterrae lour into fine powders; adding water into residual picria felterrae lour, the herba sarcandrae, the senecio, and the like and extracting to obtain extracts; adding alcohol into the extracts to carry out alcohol deposition, filtration and concentration to form thick paste; uniformly mixing, drying and pulverizing the thick paste and the picria felterrae lour fine powder to form fine powders; and adding a proper number of auxiliary materials and uniformly mixing to prepare particles or adding general preparation auxiliary materials to prepare general solid oral administration preparation. According to clinical observation for many years, the traditional Chinese medicine preparation benzyrin tablet has the obvious treating effects on a patient with upper respiratory tract infection diseases, such as upper respiratory tract inflammation, bronchitis, rhinitis, pharyngolaryngitis, tonsillitis, and the like.

A Chinese medicine for treating the cough caused by upper respiratory tract inflammation is prepared from magnolia flower, liquorice root and xanthium fruit.

An antibacterial peptide composite enzyme oral spraying agent is characterized by comprising the following components by weight: 2-8% of antibacterial peptide, 15-30% of lysozyme, 5-7% of xylitol, 3-8% of buffer, 0.5-1% of sodium chloride, 2-6% of a penetrant and balance of weakly alkaline water with the pH value of 7.3-7.5; the antibacterial peptide and the lysozyme are main materials, the xylitol, the buffer, the sodium chloride and the weakly alkaline water are auxiliary materials, the buffer is potassium dihydrogen phosphate, and the penetrant is fatty alcohol polyoxyethylene ether. The antibacterial peptide composite enzyme oral spraying agent is prepared by compounding the antibacterial peptide and the lysozyme as the main components with the buffer, the penetrant and other effective biological ingredients, large molecule ingredients of the spraying agent are transformed into small molecules by atomization, drug bacteria killing activity is improved, upper respiratory tract inflammation can be effectively controlled, helpful bacteria in the body is protected, stability is good, no drug resistance is produced, and the antibacterial peptide composite enzyme oral spraying agent is a biological oral spray, and has no toxic and side effects.

The invention relates to a new medicine compound, which is a medicine compound made up of dyers woad leaf and houttuynia by extracting effective ingredients from then concretely. The materials includes crude drug dyers woad leaf and houttuynia, the houttuynia accounts for 1-1000 shares, the weight of the dyers oad leaf is 0.1-10 times to the weight of the houttuynia. When producing the medicine, it extracts the volatile oil from the houttuynia, and blends its dredge and the dyers woad leaf together and stews them, the condensed liquid is added with clarifier and acquires the dredge extraction liquid of dyers woad leaf and houttuynia through alcohol deposition and water deposition and filter. The volatile oil and the extracted liquid are blended together, and they are processed into each kind of preparations of the medicine compound. The medicine compound can be applied to cure virus cold, upper respiratory tract inflammation, and so on.

A Chinese medicine for treating various inflammations, such as stomatitis, pharyngitis, tonsillitis, trachitis, gastritis, cholecystitis, etc, skin etching, tinea, neurodermatosis, etc is prepared from 4 Chinese-medicinal materials including spatholobus stem, Indian sinocrassula seed, soot in a bottom of a boiler and borneol.

Disclosed is a laggera pterodonta buccal tablet, its preparation process and quality control method, wherein the lozenge is prepared from Chinese medicinal herb of Winterberry Euonymus herb and right amount of auxiliary materials, the lozenge can be used for treating upper respiratory tract diseases such as pharyngitis and tonsillitis. The invention also discloses the process for measuring the content of Absinthin in the preparation.

Disclosed is a Mongolian medicament for treating respiratory tract inflammation which is prepared from the following raw materials (by weight portion): seabuckthorn fruit 10-40 parts, flavescent sophora root 12-38 parts, beach silvertop root 12-40 parts, licorice root 10-35 parts, raisin 12-36 parts, banksia rose 8-38 parts, radix rubiae 9-36 parts, cape jasmine 11-37 parts, loquat leaves 12-38 parts, alkanna tinctoria 11-39 parts, dried rehmannia root 10-20 parts, wild aconkite leaf 5-30 parts and banksia rose 10-30 parts.

The invention relates to composition containing alkaloid and essential oil which are extracted from black pepper, a preparation method thereof and application in the preparation of medicaments for treating cough, expectoration and upper respiratory tract inflammation which are caused by various reasons. The composition is superior to positive acute bronchitis syrup.

The invention provides a composition for treating upper respiratory inflammatory infection, and a preparation method of the composition. The composition is prepared from the following raw materials inparts by weight: 500-3000 parts of cranberry, 500-2000 parts of bamboo leaf flavonoid, 100-800 parts of liquorice root, 100-800 parts of fructus momordicae, 100-800 parts of pineapple, 100-800 partsof green kumquat, 100-800 parts of xylitol, 200-1000 parts of lily bulb, 100-600 parts of herba houttuyniae, 50-200 parts of herba menthae, 50-200 parts of flos chrysanthemi, 50-200 parts of honeysuckle flower, 10-100 parts of rhizoma zingiberis recens, 10-100 parts of folium eriobotryae, 10-100 parts of radix platycodon, 10-100 parts of noni fruit, 1-50 parts of elderberry, 1-50 parts of herba taraxaci and 5-20 parts of sucralose. The preparation method comprises the steps of grinding all the raw materials, screening the ground materials and then mixing. The composition provided by the invention not only can eliminate and prevent various inflammations, especially the inflammation caused by upper respiratory infection, but also can improve body immunity and repair ability, is delicious andpure in taste, natural and nutritional, thus being suitable for being taken for a long time.

The present invention provides a medicine composition for curing upper respiratory tract infection. It is a preparation made up by using houttuynia volatile oil as active component, adding proper auxiliary components through a certain preparation process. In the houttuynia volative oil the methyl-n-nonylketone is contained. Said preparation can be made into various dosage forms, including injection and oral preparation.

The invention relates to a lingdancao buccal tablet, a preparation method thereof and a method for determining the content of wormwood in a lingdancao preparation. The lingdancao buccal tablet is a buccal tablet made of a traditional Chinese medicine lingdancao and appropriate amount of auxiliary materials. The buccal tablet is absorbed through the oral mucosa, and is used for treating pharyngitis, tonsillitis and other upper respiratory tract inflammations with quick effect, good curative effect and high bioavailability. In addition, the present invention also discloses a method for determining the content of fenoxin in Lingdancao buccal preparations, the method is as follows: the flavonoid compound fennel is obtained through repeated extraction and separation from Lingdancao buccal tablets, and it is used as a reference substance, High performance liquid chromatography was used to determine the content of Aisu in Lingdancao preparation. The method is simple, rapid, high in accuracy and good in reproducibility, and has strong practicability in the production and quality control of panacea preparations.

The invention relates to a flos lonicerae and radix scutellariae solution preparation for atomization inhalation, which belongs to the field of technology of pharmaceutics. The flos lonicerae and radix scutellariae solution preparation for the atomization inhalation is prepared from (1) flos lonicerae and radix scutellariae active ingredients; and (2) isotonic agent and solvent. The solution preparation prepared by the invention fills the gap of the domestic market at present; and moreover, the solution preparation prepared by the invention is designed particularly for an atomization inhalation patient; the prepared atomization inhalation solution preparation is atomized by virtue of an ultrasonic atomizer or an air compression-type atomizer and is directly inhaled into a respiratory system in a mist form, the use process is convenient, compared with the flos lonicerae and radix scutellariae injection, an administration route is different, the use dosage is reduced, the solution preparation can take effect quickly, the safety is improved, and an effect for treating upper respiratory inflammation and pharyngitis can be better played.

The invention relates to health-care beverage for relieving a cough and removing a fire. The health-care beverage is characterized by being prepared from the raw materials by proportion: 20-30g of lilium brownie, 10-20g of xylitol, 8-10g of licorice, 20-30g of water chestnut, 10-20g of bulb of fritillary, 50-80g of purified water, 20-30g of Chinese yam and 10-15g of ginkgo. The health-care beverage has the advantages that the effects of clearing, nourishing throats, producing saliva, slaking thirst, smoothing qi and appetizing are achieved, a suppression effect on the initial upper respiratory inflammation is also achieved, and the health-care beverage is suitable for drinking by various people.

The invention relates to a medicine for treating upper respiratory track inflammation, in particular to a medicinal composition for preventing and treating upper respiratory tract inflammation and preparation and application thereof. The medicinal composition comprises the following components in percentage by weight: 40-85 percent of volatile oil, 10-55 percent of vegetable oil and 5-8 percent of an adjuvant, wherein the volatile oil comprises 30-40 percent of mint oil, 20-25 percent of asarum oil, 20-25 percent of tea tree oil, 10-15 percent of lavender oil, 5-8 percent of cinnamon oil, 0.5-0.8 percent of camphor oil and 0.5-0.8 percent of cedar oil. The medicinal composition can diffuse fast with respiratory airflow in a respiratory tract, and forms an oily thin film on the surface of respiratory mucosa and in the deep part of the respiratory tract to realize the multiple purposes of isolating sensitinogen, reducing water evaporation and releasing drugs. Aiming at the physiological characteristics of the respiratory tract, the medicinal composition particularly solves the contradiction between deep airways and administration difficulty, can enter and stay in the deep airways, meanwhile realizes protection and treatment for the respiratory mucosa, and ensures that respiratory diseases are not difficult to treat any more.

A dripping pill of senecio for treating acute conjunctitis, acute pharyngolaryngitis, acute tonsillitis, acute enteritis, acute bacterial dycentery, upper respiratory tract inflammation, etc is prepared from senecio. Its preparing process is also disclosed.

The invention relates to a traditional Chinese medicine for treating measles and a preparation method thereof. The method comprises the following steps: (1) respectively weighing the following components in parts by weight: 5-9 parts ofpolygonum perfoliatum, 7-11 parts of polygonum perfoliatum, 3-5 parts of polygonum perfoliatum, 2-7 parts of fermented soybeans, 4-9 parts of daphne genkwa, 1-3 parts of phytolacca acinosa, 7-12 parts of lytta caragana pallas, 4-8 parts of talinum paniculatum and 2-5 parts of scabious; (2) soaking the weighed polygonum perfoliatum, polygonum perfoliatum, polygonum perfoliatum, fermented soybeans and daphne genkwa into water, and filtering to obtain medicinal dregs; (3) soaking the weighed phytolacca acinosa, lytta caragana pallas, talinum paniculatum and scabious into water for 2-4 days, and filtering to obtain medicinal decoction; (4) adding the medicinal dregs and medicinal decoction into a container, decocting with slow fire for 2-5 hours, and filtering to obtain liquid; and (5) standing the liquid for one week to obtain the precipitate which is the traditional Chinese medicine for treating measles. The traditional Chinese medicine has the beneficial effects of remarkable effect, no side effect and short treatment cycle for fever, upper respiratory tract inflammation, conjunctivitis, red maculopapule on skin and the like caused by measles.

A traditional Chinese medicine for treating dry rhinitis. Rhinitis sicca is a common disease, common in cold winter, a kind of upper respiratory tract inflammation caused by dry climate, manifested as nosebleeds, nasal congestion, discomfort, dyspnea and other symptoms. Affect people's normal work and life. There are many medicines for treating rhinitis sicca in the market, but the cost is higher and the cure is slower. In order to solve the above problems, the present invention is to configure a Chinese medicine for treating rhinitis sicca. It has the effects of nourishing yin, reducing inflammation, and opening up the orifices. The invention is made of pure traditional Chinese medicine, and the specific Chinese medicine formula is: Eclipta chinensis, cocklebur, angelica dahurica, vitriol, mint, salvia miltiorrhiza, magnolia flower.

A xylitol beverage for moistening throat, promoting appetite, and suppressing the initial upper respiratory tract inflammation is prepared from distilled water or purified water or mineral spring water, xylitol, and 10 Chinese-medicinal materials including dogwood fruit, mint oil, borneol, pearl powder, liquorice root, etc.

A Chinese medicine for treating laryngolaryngitis and upper respiratory tract inflammation is prepared from 10 Chinese-medicinal materials including scrophularia root, ophiopogon root, ciccada slough, myrobalan seed, etc through proportionally mixing, extracting and mixing with sugar or syrup and additive.

The invention provides a nasal drop for treating an inflammation of an upper respiratory tract. The nasal drop comprises the following raw materials in parts by weight: 5-25 parts of rhizoma atractylodis, 5-20 parts of dried tangerine peels, 10-25 parts of magnolia barks, 5-25 parts of radix angelicae, 5-20 parts of poria cocos, 10-25 parts of areca peels, 5-20 parts of unprocessed rhizoma pinelliae, 10-25 parts of flower buds of lily magnolia, 5-25 parts of herba schizonepetae, 5-20 parts of fructus liquidambaris, 8-15 parts of radish seeds, 8-15 parts of mustard seeds, 5-20 parts of perillaseeds, 5-20 parts of fructus schizandrae, 5-15 parts of ligusticum sinense olivers, 5-15 parts of rhizoma cimicifugae and 10-25 parts of sesame oil. The nasal drop has the beneficial effects of clearing away pathogenesis products attached and silted on tissue of the surface layer and lower layer of a mucosa of the upper respiratory tract and thoroughly treating the inflammation of the upper respiratory tract and is applicable to the field of medicines.

The invention provides a Yao nationality medicine composition for preventing and treating upper respiratory tract inflammation and belongs to the technical field of ethnic medicines. The Yao nationality medicine composition comprises arrowshaped tinospora roots, mint, radix sophorae subprostratae, citronella, lysimachia foenum-graecum, radix fici simplicissimae, magnolia flowers, agastache rugosusand rhizoma acori graminei. The Yao nationality medicine composition provided by the invention has an effective rate of 80-93.33% on upper respiratory tract inflammation and is free of adverse reactions.

A xylitol beverage for moistening throat, promoting appetite, and suppressing the initial upper respiratory tract inflammation is prepared from distilled water or purified water or mineral spring water, xylitol, and 10 Chinese-medicinal materials including dogwood fruit, mint oil, borneol, pearl powder, liquorice root, etc.